Nicholas Haft - Net Worth and Insider Trading
Nicholas Haft Net Worth
The estimated net worth of Nicholas Haft is at least $179,856 dollars as of 2024-06-08. Nicholas Haft is the Director of Finch Therapeutics Group Inc and owns about 135,230 shares of Finch Therapeutics Group Inc (FNCH) stock worth over $179,856. Details can be seen in Nicholas Haft's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nicholas Haft has not made any transactions after 2021-12-20 and currently still holds the listed stock(s).
Transaction Summary of Nicholas Haft
Nicholas Haft Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nicholas Haft owns 1 companies in total, including Finch Therapeutics Group Inc (FNCH) .
Click here to see the complete history of Nicholas Haft’s form 4 insider trades.
Insider Ownership Summary of Nicholas Haft
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FNCH | Finch Therapeutics Group Inc | 2022-06-13 | director |
Nicholas Haft Latest Holdings Summary
Nicholas Haft currently owns a total of 1 stock. Nicholas Haft owns 135,230 shares of Finch Therapeutics Group Inc (FNCH) as of December 20, 2021, with a value of $179,856.
Latest Holdings of Nicholas Haft
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FNCH | Finch Therapeutics Group Inc | 2021-12-20 | 135,230 | 1.33 | 179,856 |
Holding Weightings of Nicholas Haft
Nicholas Haft Form 4 Trading Tracker
According to the SEC Form 4 filings, Nicholas Haft has made a total of 2 transactions in Finch Therapeutics Group Inc (FNCH) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Finch Therapeutics Group Inc is the acquisition of 2,128 shares on December 20, 2021, which cost Nicholas Haft around $649,993.
Insider Trading History of Nicholas Haft
- 1
Nicholas Haft Trading Performance
GuruFocus tracks the stock performance after each of Nicholas Haft's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nicholas Haft is -21.71%. GuruFocus also compares Nicholas Haft's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nicholas Haft within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nicholas Haft's insider trading performs compared to the benchmark.
Performance of Nicholas Haft
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.39 | | | | | |
| Relative Return to S&P 500(%) | -15.9 | | | | | |
Nicholas Haft Ownership Network
Nicholas Haft Owned Company Details
What does Finch Therapeutics Group Inc do?
Who are the key executives at Finch Therapeutics Group Inc?
Nicholas Haft is the director of Finch Therapeutics Group Inc. Other key executives at Finch Therapeutics Group Inc include Chief Financial Officer Lance E Thibault , Chief Executive Officer Matthew P. Blischak , and Chief Business & Legal Officer Joseph Vittiglio .
Finch Therapeutics Group Inc (FNCH) Insider Trades Summary
Over the past 18 months, Nicholas Haft made no insider transaction in Finch Therapeutics Group Inc (FNCH). Other recent insider transactions involving Finch Therapeutics Group Inc (FNCH) include a net sale of 9,712 shares made by Jeffery A Smisek , and a net purchase of 5,010 shares made by Susan E Graf .
In summary, during the past 3 months, insiders sold 8,242 shares of Finch Therapeutics Group Inc (FNCH) in total and bought 0 shares, with a net sale of 8,242 shares. During the past 18 months, 9,712 shares of Finch Therapeutics Group Inc (FNCH) were sold and 167 shares were bought by its insiders, resulting in a net sale of 9,545 shares.
Finch Therapeutics Group Inc (FNCH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Finch Therapeutics Group Inc Insider Transactions
Nicholas Haft Mailing Address
Above is the net worth, insider trading, and ownership report for Nicholas Haft. You might contact Nicholas Haft via mailing address: C/o Finch Therapeutics Group, Inc., 200 Inner Belt Road, Suite 400, Somerville Ma 02143.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
